Image

BRING-UP Prevention

BRING-UP Prevention

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The aim of this observational study is to assess in patients with a documented athero-thrombotic event: coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral artery disease (PAD):

  • the level of adherence to guideline recommendations with the assumption to improve the rate of patients at goal for cholesterol levels.
  • the level of adherence to guideline recommendations and the rate of patients at goal for the other relevant and modifiable risk factors for cardiovascular event recurrence.

Description

Observational, prospective, multicenter study conducted in a large, representative sample of Italian cardiology centers.

Phases
  1. First educational intervention to discuss the recommendations of guidelines for secondary prevention strategies.
  2. Data collection for 3 months or up to 30 consecutive patients in patients with documented CAD/CVD/PAD on a web Case Record Form (CRF) generating warning on the most relevant guideline recommendations, and, when guidelines are not followed, asking the reason for non-adherence.
  3. Evaluation of the primary and secondary end-points of the study at 6 months after enrollment.
  4. Second educational intervention to share the results of the first enrollment period of the study focusing the attention on existing gaps between guidelines recommendations and clinical practice.
  5. New data collection for 3 months or up to 30 consecutive patients in patients with documented CAD/CVD/PAD on a web CRF generating warning on the most relevant guideline recommendations, and, when guidelines are not followed, asking the reason for non-adherence.
  6. Additional evaluation of the primary and secondary end-points of the study at 6 months after enrollment.
  7. 12-month follow-up for all patients included in both enrolment phases.

Eligibility

Inclusion Criteria:

  • Both sexes at birth, age ≥18 years

At least one of the following clinical conditions:

  • Documented CAD defined as:
    • Prior Acute Coronary Syndrom (ACS)
    • Prior Coronary Artery Bypass Graft (CABG)
    • Prior Percutaneous Coronary Intervention (PCI)
  • Documented PAD (previous peripheral bypass surgery or angioplasty, limb or foot

    amputation, intermittent claudication with objective evidence of peripheral artery disease, Ankle Brachial Index (ABI)<90).

  • Documented CVD: Ischemic stroke, previous carotid vascular interventions.
  • Signed informed consent.

Exclusion Criteria:

  • Active neoplasia or very severe disease compromising short-medium term life expectancy.
  • Participation in interventional studies.
  • Patients already enrolled into the study from another participating center or in the previous enrolling phase.

Study details
    Ischemic Heart Disease
    Cerebrovascular Disorders
    Peripheral Arterial Disease

NCT06275113

Heart Care Foundation

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.